Stay updated on Optimal Pharmacotherapy on Lipids/Plaques in Atherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Optimal Pharmacotherapy on Lipids/Plaques in Atherosclerosis Clinical Trial page.

Latest updates to the Optimal Pharmacotherapy on Lipids/Plaques in Atherosclerosis Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the way information is presented.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check111 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact for assistance.SummaryDifference6%
Stay in the know with updates to Optimal Pharmacotherapy on Lipids/Plaques in Atherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Pharmacotherapy on Lipids/Plaques in Atherosclerosis Clinical Trial page.